Danielle Olivia Dwyer, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Topoisomerase II Inhibitors | 1 | 2007 | 94 | 0.280 |
Why?
|
| Systems Biology | 1 | 2008 | 481 | 0.240 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2009 | 587 | 0.240 |
Why?
|
| Oxidative Stress | 4 | 2009 | 3108 | 0.210 |
Why?
|
| Reactive Oxygen Species | 1 | 2009 | 2137 | 0.190 |
Why?
|
| Bacteria | 2 | 2010 | 2217 | 0.190 |
Why?
|
| Bacterial Infections | 1 | 2009 | 1406 | 0.190 |
Why?
|
| Escherichia coli | 5 | 2008 | 4234 | 0.170 |
Why?
|
| Hydroxyl Radical | 3 | 2008 | 82 | 0.160 |
Why?
|
| Anti-Bacterial Agents | 4 | 2010 | 7424 | 0.160 |
Why?
|
| Enzyme Inhibitors | 1 | 2007 | 3710 | 0.130 |
Why?
|
| Ribonucleotides | 1 | 2010 | 114 | 0.090 |
Why?
|
| Microbial Viability | 1 | 2007 | 238 | 0.070 |
Why?
|
| Respiratory Tract Diseases | 1 | 2011 | 748 | 0.060 |
Why?
|
| Interdisciplinary Communication | 1 | 2011 | 931 | 0.060 |
Why?
|
| Postoperative Care | 1 | 2011 | 1471 | 0.060 |
Why?
|
| Checklist | 1 | 2011 | 827 | 0.060 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2011 | 1017 | 0.060 |
Why?
|
| Genetic Engineering | 2 | 2006 | 933 | 0.050 |
Why?
|
| DNA, Bacterial | 1 | 2007 | 1481 | 0.050 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2004 | 415 | 0.050 |
Why?
|
| Protein Biosynthesis | 1 | 2008 | 2114 | 0.050 |
Why?
|
| Ribosomes | 1 | 2004 | 501 | 0.050 |
Why?
|
| Disease Management | 1 | 2011 | 2501 | 0.050 |
Why?
|
| RNA, Untranslated | 1 | 2004 | 459 | 0.050 |
Why?
|
| Adenosine Triphosphate | 1 | 2007 | 1989 | 0.040 |
Why?
|
| RNA | 2 | 2010 | 2721 | 0.040 |
Why?
|
| Staphylococcus aureus | 1 | 2007 | 1459 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2008 | 3685 | 0.040 |
Why?
|
| Iron | 1 | 2007 | 1787 | 0.040 |
Why?
|
| Transcriptional Activation | 1 | 2004 | 1753 | 0.040 |
Why?
|
| Gene Silencing | 1 | 2004 | 1509 | 0.040 |
Why?
|
| DNA Damage | 1 | 2007 | 2441 | 0.040 |
Why?
|
| Gene Expression | 2 | 2007 | 7582 | 0.040 |
Why?
|
| Membrane Proteins | 2 | 2008 | 7849 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 1999 | 1152 | 0.030 |
Why?
|
| Herpesvirus 4, Human | 1 | 1999 | 1078 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2011 | 5332 | 0.030 |
Why?
|
| Genomics | 1 | 2008 | 5806 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2006 | 12785 | 0.030 |
Why?
|
| Viral Proteins | 1 | 1999 | 1803 | 0.030 |
Why?
|
| Cell Division | 1 | 1999 | 4461 | 0.020 |
Why?
|
| Gene Expression Regulation, Bacterial | 2 | 2008 | 1133 | 0.020 |
Why?
|
| Rifamycins | 1 | 2010 | 26 | 0.020 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2010 | 110 | 0.020 |
Why?
|
| Trans-Activators | 1 | 1999 | 2858 | 0.020 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2010 | 119 | 0.020 |
Why?
|
| Protein Denaturation | 1 | 2008 | 242 | 0.020 |
Why?
|
| 2,2'-Dipyridyl | 1 | 2007 | 10 | 0.020 |
Why?
|
| Aminoglycosides | 1 | 2008 | 163 | 0.020 |
Why?
|
| Carbon-Sulfur Lyases | 1 | 2007 | 11 | 0.020 |
Why?
|
| Norfloxacin | 1 | 2007 | 24 | 0.020 |
Why?
|
| Kanamycin | 1 | 2007 | 64 | 0.020 |
Why?
|
| Ferrous Compounds | 1 | 2007 | 41 | 0.020 |
Why?
|
| Rec A Recombinases | 1 | 2007 | 50 | 0.020 |
Why?
|
| Ampicillin | 1 | 2007 | 142 | 0.020 |
Why?
|
| Models, Genetic | 2 | 2008 | 3445 | 0.020 |
Why?
|
| Colony Count, Microbial | 1 | 2007 | 330 | 0.020 |
Why?
|
| Cell Wall | 1 | 2010 | 425 | 0.020 |
Why?
|
| Quinolones | 1 | 2010 | 378 | 0.020 |
Why?
|
| Free Radical Scavengers | 1 | 2007 | 211 | 0.020 |
Why?
|
| Postoperative Period | 1 | 2011 | 1807 | 0.020 |
Why?
|
| Iron Chelating Agents | 1 | 2007 | 141 | 0.020 |
Why?
|
| Citric Acid Cycle | 1 | 2007 | 230 | 0.020 |
Why?
|
| Hydroxyurea | 1 | 2007 | 282 | 0.020 |
Why?
|
| RNA, Catalytic | 1 | 2006 | 53 | 0.020 |
Why?
|
| Safety Management | 1 | 2011 | 760 | 0.020 |
Why?
|
| Protein Folding | 1 | 2008 | 867 | 0.010 |
Why?
|
| Patient Transfer | 1 | 2011 | 793 | 0.010 |
Why?
|
| Hydrogen Peroxide | 1 | 2007 | 728 | 0.010 |
Why?
|
| NAD | 1 | 2007 | 614 | 0.010 |
Why?
|
| DNA Replication | 1 | 2010 | 1418 | 0.010 |
Why?
|
| 5' Untranslated Regions | 1 | 2004 | 256 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2008 | 2227 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 1999 | 9598 | 0.010 |
Why?
|
| Drug Discovery | 1 | 2010 | 1054 | 0.010 |
Why?
|
| Cell Death | 1 | 2007 | 1664 | 0.010 |
Why?
|
| Gene Expression Profiling | 2 | 2008 | 9410 | 0.010 |
Why?
|
| Escherichia coli Proteins | 1 | 2007 | 1067 | 0.010 |
Why?
|
| Ligands | 1 | 2006 | 3270 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2004 | 2060 | 0.010 |
Why?
|
| Massachusetts | 1 | 2011 | 8826 | 0.010 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 1999 | 439 | 0.010 |
Why?
|
| Microfilament Proteins | 1 | 1999 | 1134 | 0.010 |
Why?
|
| Computational Biology | 1 | 2006 | 3510 | 0.010 |
Why?
|
| HeLa Cells | 1 | 1999 | 3097 | 0.010 |
Why?
|
| Models, Biological | 1 | 2008 | 9462 | 0.010 |
Why?
|
| Blotting, Western | 1 | 1999 | 5031 | 0.010 |
Why?
|
| Cell Cycle | 1 | 1999 | 2929 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 39078 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 1999 | 2911 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2006 | 11900 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1999 | 13445 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2011 | 54339 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 1999 | 17639 | 0.000 |
Why?
|
| Time Factors | 1 | 2007 | 39947 | 0.000 |
Why?
|
| Child | 1 | 2011 | 80086 | 0.000 |
Why?
|
| Mutation | 1 | 2007 | 30025 | 0.000 |
Why?
|
| Signal Transduction | 1 | 1999 | 23397 | 0.000 |
Why?
|
| Humans | 2 | 2011 | 760437 | 0.000 |
Why?
|
| Animals | 1 | 2004 | 168253 | 0.000 |
Why?
|